Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies
| New Aspects of Cancer Stem Cell Biology : Implications for Innovative Therapies |
| Autore | Cavallaro Ugo |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (208 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
ALDH1
ATAC-seq B4GALT1 bevacizumab bowel cancer breast cancer Cadherin 11 cancer stem cell cancer stem cells cancer therapy cell adhesion molecule chemo-resistance chemoresistance chemotherapy resistance colon colorectal CSCs dasatinib early breast cancer EC-8042 epithelial-mesenchymal transition exosomes genetic heterogeneity genome-wide HDAC inhibitors head and neck squamous cell carcinoma immunohistochemistry L1CAM lipid LUAD lung cancer metabolism neoadjuvant chemotherapy NSCLC oral cancer risk oral epithelial dysplasia oral squamous cell carcinoma organoid ovarian cancer Ovarian cancer RNA-seq saracatinib SNP array solid cancer SOX2 SRC stem cell therapeutic resistance therapy resistance TNBC transcriptome tumor progression tumoroid Wnt signaling WNT signaling β-catenin |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | New Aspects of Cancer Stem Cell Biology |
| Record Nr. | UNINA-9910557112003321 |
Cavallaro Ugo
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Precision Medicine in Solid Tumors
| Precision Medicine in Solid Tumors |
| Autore | Dey Nandini |
| Descrizione fisica | 1 online resource (304 p.) |
| Soggetto topico |
Medicine and Nursing
Oncology |
| Soggetto non controllato |
adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase breast cancer cancer cancer-associated fibroblasts cfDNA chemotherapy circulating free DNA clinical guideline clonality classification comprehensive genomic profiling CTC ctDNA DDR genes Decision tree digital enrichment driver mutation EGFR mutation EGFR-TKI electronic records epidermal growth factor receptor extent of resection gene panel sequencing glioblastoma prognosis HNSCC immune checkpoint inhibitors immunocytochemistry immunotherapy intratumor heterogeneity laboratory-friendly liquid biopsy molecular barcoding molecular genotyping multiple biopsies n/a new drug development next-generation sequencing next-generation sequencing (NGS) NGS non-small cell lung cancer open data osimertinib outcome overall survival parallel double-detection PARP inhibitors PD-L1 pediatric tumors personalized precision oncology precision medicine presumed germline findings random forest regulatory reform resistance screening sequencing smoking solid cancer strategic therapeutic intervention targeted therapy tDNA thymoma TMB TNBC subtypes triple-negative breast cancer (TNBC) tumor evolution tumor mutational burden tumor profiling test tyrosine kinase inhibitor universal health-care system whole-exome sequencing |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910595078103321 |
|
Dey Nandini
|
||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||